Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

JAK3 anticorps (AA 601-700) (Cy3)

Cet anticorps Lapin Polyclonal détecte spécifiquement JAK3 dans WB, FACS, IF (cc) et IF (p). Il présente une réactivité envers Humain et Souris.
N° du produit ABIN681016

Aperçu rapide pour JAK3 anticorps (AA 601-700) (Cy3) (ABIN681016)

Antigène

Voir toutes JAK3 Anticorps
JAK3 (Janus Kinase 3 (JAK3))

Reactivité

  • 76
  • 41
  • 19
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain, Souris

Hôte

  • 75
  • 7
Lapin

Clonalité

  • 63
  • 19
Polyclonal

Conjugué

  • 39
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp JAK3 est conjugé à/à la Cy3

Application

  • 50
  • 28
  • 16
  • 14
  • 13
  • 13
  • 11
  • 9
  • 7
  • 7
  • 3
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Épitope

    • 15
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 601-700

    Specificité

    This has 85 % sequence similarity with JAK1 and may cross-react.

     Réactivité croisée

    Humain, Souris

    Homologie

    Rat,Dog,Cow,Pig,Horse

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human Jak3

    Isotype

    IgG
  • Indications d'application

    FCM 1:20-100
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Date de péremption

    12 months
  • Antigène

    JAK3 (Janus Kinase 3 (JAK3))

    Autre désignation

    Jak3

    Sujet

    Synonyms: JAKL, LJAK, JAK-3, L-JAK, JAK3_HUMAN, Tyrosine-protein kinase JAK3, Janus kinase 3, Leukocyte janus kinase, JAK3

    Background: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, upon IL2R activation by IL2, JAK1 and JAK3 Molecules bind to IL2R beta (IL2RB) and gamma chain (IL2RG) subunits inducing the tyrosine phosphorylation of both receptor subunits on their cytoplasmic domain. Then, STAT5A AND STAT5B are recruited, phosphorylated and activated by JAK1 and JAK3. Once activated, dimerized STAT5 translocates to the nucleus and promotes the transcription of specific target genes in a cytokine-specific fashion.

    ID gène

    3718

    UniProt

    P52333

    Pathways

    Signalistation JAK/STAT, Signalisation RTK, Response to Growth Hormone Stimulus, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus, Activated T Cell Proliferation, Unfolded Protein Response
Vous êtes ici:
Chat with us!